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ABSTRACT
The RNA transcriptome varies in response to
cellular differentiation as well as environmental
factors, and can be characterized by the diversity
and abundance of transcript isoforms. Differential
transcription analysis, the detection of differences
between the transcriptomes of different cells, may
improve understanding of cell differentiation and
development and enable the identification of bio-
markers that classify disease types. The availability
of high-throughput short-read RNA sequencing
technologies provides in-depth sampling of the
transcriptome, making it possible to accurately
detect the differences between transcriptomes. In
this article, we present a new method for the detec-
tion and visualization of differential transcription.
Our approach does not depend on transcript or
gene annotations. It also circumvents the need for
full transcript inference and quantification, which is
a challenging problem because of short read
lengths, as well as various sampling biases.
Instead, our method takes a divide-and-conquer
approach to localize the difference between tran-
scriptomes in the form of alternative splicing
modules (ASMs), where transcript isoforms
diverge. Our approach starts with the identification
of ASMs from the splice graph, constructed directly
from the exons and introns predicted from RNA-seq
read alignments. The abundance of alternative
splicing isoforms residing in each ASM is estimated
for each sample and is compared across sample
groups. A non-parametric statistical test is applied
to each ASM to detect significant differential tran-
scription with a controlled false discovery rate.
The sensitivity and specificity of the method have
been assessed using simulated data sets and
compared with other state-of-the-art approaches.
Experimental validation using qRT-PCR confirmed
a selected set of genes that are differentially
expressed in a lung differentiation study and a
breast cancer data set, demonstrating the utility of
the approach applied on experimental biological
data sets. The software of DiffSplice is available at
http://www.netlab.uky.edu/p/bioinfo/DiffSplice.
INTRODUCTION
The messenger RNA (mRNA) transcriptome consists of
all mRNA molecules transcribed from the genome within
a functioning cell. Different genes give rise to different
transcripts with varying abundance. In addition, through
the mechanism of alternative splicing, different subsets
of exons in a gene may be concatenated (in transcrip-
tion order) to form different transcript isoforms (1–4).
The diversity and abundance of isoforms transcribed
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from a gene are known to vary in response to cellular
differentiation and maturation, as well as environmental
factors and disease. The totality of transcripts present, and
their individual abundance, characterizes the mRNA tran-
scriptome and is a most basic phenotype. Thus, the differ-
ence between transcriptomes sampled from healthy and
diseased cells may provide insight into the functional con-
sequences of disease, as well as identifying biomarkers to
classify different disease types (5). Similarly, the difference
between transcriptomes sampled at different stages in cell
development may provide insight into the functional
effects of cell differentiation and cell life cycles (2,6).
Classically, the differential analysis of transcriptomes
has been studied using techniques such as microarray
technologies (7) that identify differences in the total
expression of known gene transcripts and exon arrays
(8,9) that detect differences in the expression of known
gene exons. More recently, high-throughput sequencing
methods, such as RNA-seq (10), have been able to accur-
ately record short sequences of nucleotides sampled from
millions of mRNA molecules in the transcriptome, and
thereby are capable of observing samples from known
and unknown transcripts, providing a more complete
picture of the transcriptome. In addition, the large
number of molecules sampled provides the potential to
accurately estimate relative abundance of transcript
isoforms.
Three basic strategies have emerged to identify ‘differ-
ential transcription’, the difference in the relative
abundance of the individual transcripts across samples.
The first strategy, e.g. Cufflinks (6), performs transcript
inference and abundance estimation followed by differen-
tial test of relative abundance. Such an approach is ideal,
but its performance relies on accurate transcript quantifi-
cation, which is itself a challenging problem. The
RNA-seq reads generated by most sequencing platforms
are <100 nt single or paired ends. In genes with a signifi-
cant number of very similar alternative transcripts, they
are too short to be assigned to individual transcripts un-
ambiguously, making the transcript quantification
problem underdetermined. Figure 1 demonstrates a gene
with four isoforms as a result of two alternative splicing
events. Transcripts could start and end at any exon, or
even within exons. Assuming no transcript annotation
is known, there can be more than one set of valid tran-
scripts, as shown in Figure 1b. Even with four known
transcripts as given, there could be multiple solutions
of valid quantification (Figure 1c). In this case, the
problem of transcript quantification is ‘unidentifiable’
(11) and may result in inaccurate abundance estimation.
Consequentially, the uncertainty in transcript quantifica-
tion may lead to false discoveries of genes with differential
transcription.
The second strategy indirectly detects differential tran-
scription by aggregating changes of multiple features on
the transcriptome (12,13). For example, a non-parametric
statistical test called maximum mean discrepancy was
designed in (12) for the comparison of read coverage on
all exons. Flow difference metric (FDM) was designed to
capture the average flow difference of all divergence nodes
(a)
(b)
(d)
(e)
(c)
Figure 1. Challenges in using short reads to identify transcripts and their abundance. (a) An example of alternatively spliced gene with five exons.
Each black rectangle denotes an exon, and the arrows denote the splice junctions connecting the exons. Two alternative splicing events are present in
this model: exon E2 can be alternatively included or skipped by transcripts passing through E1 and E3, and transcripts passing through exon E3 may
alternatively end in E4 or E5. (b) Viable transcript sets of the gene in (a). Without transcript annotations, more than one transcript set, for example,
transcript sets A and B, may explain the splice variants suggested by the alternative splice junctions. (c) Even when starting from a known set of
transcripts, the procedure of estimating transcript abundance could be underdetermined: two different transcript expression profiles of the transcript
set A explain the exon coverage observed using alignments of short reads to exons. (d) The representation of alternative splicing used by DiffSplice.
Instead of inferring transcripts and estimating their abundance, DiffSplice infers ASMs where different transcripts diverge. ASM1 captures the
inclusion or skipping of exon E2. ASM2 captures the alternative 3
0-end at either E4 or E5. Quantitation of different paths through an ASM is
performed at the module level. (e) The distribution of the number of alternative transcripts per gene with UCSC human hg19 RefSeq annotation and
the number of alternative paths per ASM after decomposition. The plot shows ASMs have significantly fewer alternative paths. The reduced
complexity allows more accurate quantification.
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between two splice graphs (13). These approaches do not
rely on any transcript information. However, they provide
no simple localization of differences: maximum mean dis-
crepancy and FDM can only detect a diffuse ‘signal’ of
differential transcription without identifying the specific
isoforms or regions that give rise to the difference.
The last strategy examines differential expression on
annotated simple alternative transcription events in
existing splicing databases. Examples include ALEXA-
seq (14), MISO (15), SpliceTrap (16) and MATS (17).
These methods have been shown to be accurate in iden-
tifying differences in utilization of a skipped exon by
isoforms in two samples. However, they do not extend
easily to more complex alternative splicing patterns with
more than two alternative splice forms. These methods
cannot be easily generalized to accommodate novel alter-
native splicing events that can be discovered by RNA-seq
data, consequentially misinterpreting the data and the
splicing events.
In this article, we present an ab initio method named
DiffSplice for the detection and visualization of differen-
tial alternative transcription. DiffSplice circumvents the
need for full-length transcript inference and quantification
and localizes its search at alternative splicing modules
(ASMs) (Figure 1d). These modules represent the
genomic regions, where alternative transcripts diverge,
localizing the nature of the difference and decreasing the
complexity of the differential analysis by comparing
corresponding ASMs between samples (Figure 1e). The
ASMs are detected automatically from a transcriptome-
wide expression-weighted splice graph (ESG), which is
built directly from read alignments and captures all the
sample-relevant splicing events including novel ones.
Expression estimation of associated isoforms and tests
for differential transcription start from the simplest
ASMs, which yield estimation that is more robust to
sequencing bias, and work outward. A non-parametric
statistical test is introduced to assign the significance
level of the differential transcription in the ASMs with
a controlled false discovery rate (FDR). By design,
differential analysis on ASM can be performed using
short reads.
Our results on synthetic data sets demonstrate the
precision of DiffSplice in the discovery and the expression
estimation of ASMs and hence the sensitivity in the quan-
titation of transcriptional differences between samples.
Simulation experiments on human transcriptome
support the robustness of our method at different
sampling depths and under various sampling biases. We
applied DiffSplice on a time course lung differentiation
data set, where 498 genes were tested to have significant
change of transcription, as well as 2077 with significant
change of overall gene expression, supporting the hypoth-
esis that differential transcription is the key in the
mucociliary cell differentiation and function. We also
discovered 910 novel alternative splicing events that were
not present in existing RefSeq and UCSC transcript
annotations. The consideration of replicates in test
statistics allowed DiffSplice to account for sample vari-
ations, reducing the risk of unreliable discoveries.
Beyond the scope of differential transcription in
alternatively spliced exons, the application of the
proposed method on a breast cancer data set led to the
discovery of cell line-specific structural variations such as
deletions, demonstrating the feasibility in identifying ir-
regular transcription variants that may reveal crucial regu-
latory mechanism in a cancer transcriptome.
MATERIALS AND METHODS
The major steps of DiffSplice are illustrated in Figure 2.
DiffSplice starts by reconstructing a transcriptome-wide
splice graph from the union of the RNA-seq read align-
ments from all samples, providing a survey of all possible
alternative splicing and transcription events. The splice
graph is a directed acyclic graph, the nodes of which rep-
resent expressed exonic units while two exonic units are
connected by an edge if there exist reads whose alignment
spans both units, such as spliced reads. DiffSplice then
automatically identifies genomic regions corresponding
to ASMs. In the splice graph, they correspond to the
single-entry single-exit subgraphs with diverging paths in
between, where the diverging paths distinguish alternative
splicing isoforms. Isoform abundance estimation is then
applied at the level of the diverging paths based on read
distribution in each sample. A test statistic is designed to
evaluate the difference of the diversity of the alternative
transcript fragments between groups. The significance of
the test is assessed through a non-parametric permutation
test. In this way, DiffSplice localizes the detection of
splicing isoforms that are differentially expressed at indi-
vidual ASMs.
Accurate construction of transcriptome-wide ESG
Traditionally, the transcriptome is either represented by
a list of transcripts (6) or a splice graph (13,19,20). In
comparison, a list of individual transcripts encodes the
complete set of transcriptional information, whereas
a splice graph summarizes the variation among multiple
transcripts and clearly shows the exons that may be
spliced out during transcription, as well as the exons
that are always retained. With RNA-seq reads, the predic-
tion of individual exons and splice junctions has become a
routine, allowing accurate reconstruction of the splice
graph. The prediction of full-length mRNA transcripts
remains challenging, especially for genes with highly
complex alternative splicing events. Therefore, our
method starts with the construction of a splice graph.
The splice graph is built from the RNA-seq read align-
ments to the reference genome. Alternatively, it can be
built de novo by assembly of RNA-seq reads (21–23).
The alignment of RNA-seq reads to a reference genome
has been studied extensively in the past 2 years (18,24,25).
There exist two types of read alignments, exonic align-
ments and spliced alignments. An exonic alignment
corresponds to a contiguous sequence of nucleotides on
the genome, typically indicating expressed exonic regions.
A spliced alignment spans two or more exons, consequen-
tially defining the donor and acceptor sites of the splice
junctions. For paired-end reads (PER), DiffSplice first
applies MapPER (19) to determine the whole transcript
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Figure 2. DiffSplice discovers genome-wide differential splicing events using RNA-seq data. (a) The alignment of RNA-seq reads. Sequenced
RNA-seq short reads are first mapped to the reference genome using RNA-seq read aligner such as MapSplice (18). In the presence of PERs,
MapPER (19) can be applied to find alignments for the entire transcript fragments based on the distribution of insert size, which further consolidates
the prediction of splice junctions. (b) The observed read coverage on the reference genome. The read coverage of different samples may differ in the
overall gene expression, indicating differential expression level of the gene, or differ in the relative expression of alternatively spliced exons, indicating
differential transcription of the transcript isoforms. (c) The decomposition of the splice graph and the discovery of ASM. DiffSplice constructs the
transcriptome-wide ESG from the RNA-seq alignments. The graph summarizes transcription information in all samples regarding splice structure, as
well as expression. The exonic units and splice junctions constitute the vertices and edges, respectively, for the ESG. The ESG is further augmented
by adding a virtual transcription start node ts and a virtual transcription end node te. DiffSplice then resolves alternatively spliced genomic regions
by iteratively decomposing the ESG into ASMs. Every ASM is a subgraph bounded by a pre/post-dominator pair. A more complex example is
shown in the supplemental material for gene VEGFA (Supplementary Figure S1). The decomposition of the ESG results in a hierarchy of ASMs that
describes how transcripts diverge and reconvene. The alternative paths define the alternative ways of transcription in each ASM. (d) The abundance
estimation for all ASM paths. For every sample, DiffSplice estimates the abundance and the relative proportion of every alternative transcription
path. Subsequently, the estimators for the expression of each ASM are propagated to derive an estimator for the overall gene expression. (e) The
statistical tests for significant differences in transcription and gene expression. The test statistic for differential transcription in every ASM is designed
to evaluate consistent divergence between alternative path proportions in the sample groups. The differential expression level for each gene is
similarly evaluated by testing the estimated gene expression. DiffSplice uses a non-parametric permutation test to select significant differences
between sample groups, alleviating the risk of inappropriate assumption on the distribution of the test statistics.
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fragment alignments according to the distribution of the
expected mate-pair distance (Figure 2a), which allows
more accurate splice prediction and expression profiling.
In a splice graph G ¼ hV,E,wi, every node corresponds
to an exonic unit, an expressed region on the genome
whose boundaries are delimited by donor and acceptor
splice sites defined by the location of splice junctions.
It is difficult to detect the precise transcription start and
end sites with RNA-seq reads from commonly used
library preparation protocols. They are therefore
estimated as the locations where read coverage changes
significantly from absence to presence and vice versa
relative to background, respectively. With alternative
splice sites, part of an exon can be skipped in one tran-
script but not in others. In this case, a continuous exonic
region will be further divided into smaller units, allowing
each of them to be alternatively included in transcripts.
As the exonic units are linearly ordered on the reference
genome, nodes in V can be ordered based on their loca-
tions on the genome. We say vs < ve if the location of vs is
upstream of ve in the direction of transcription. Two
exonic units will be connected by an edge if there exist
read alignments that contiguously cover both of them.
The direction of the edge is determined by the direction
of the transcription identified by the dinucleotide se-
quences in the intron flanking the donor and acceptor
sites. For example, a GT–AG dinucleotide pair flanking
the intron sequences in the reference genome suggests
forward transcription, whereas the CT–AC pair suggests
the reverse transcription. The expression levels on the
exonic units and the splice junctions are then collected
as the weights w of the vertices and the edges.
To make the description of the following algorithm
easier, we further augment the general splice graph
G ¼ hV,E,wi by adding a virtual transcription start node
ts and a virtual transcription end node te. Edges will be
added to connect the start node ts to all the vertices where
transcripts initiate and similarly to connect all the vertices
where transcripts terminate to the end node te. Therefore,
all transcripts in a gene will start from ts and end in te. We
also assume for every vertex v 2 V there is a directed path
from ts to v and a directed path from v to te, that is, every
exonic segment can be reached by some transcript in the
gene. We refer to the augmented splice graph as the ESG.
Detection of ASM
Next, we identify alternative exonic events through the
decomposition of the ESG into ASMs. An ASM is
defined as a single-entry and single-exit subgraph of the
splice graph. The entry node is the only exonic unit where
transcripts can flow into the ASM; similarly, the exit node
is the only node where transcripts leave the ASM.
Transcripts diverge into more than one isoforms by fol-
lowing different paths in the ASM before reconvening at
the exit node.
Let G ¼ hV,E,ts,te,wi be the ESG of a gene. A vertex
u 2 V ‘pre-dominates’ a vertex v 2 V if every path from
the transcription start ts to v (include v) contains u.
A vertex w 2 V ‘post-dominates’ a vertex v 2 V if every
path from v to the transcription end te (include v)
contains w. Additionally, u/ w is the ‘immediate’
pre/post-dominator of v if every other vertex x 2 V that
pre/post-dominates v also dominates u/ w. We define the
out-degree and the in-degree of a vertex v 2 V as the
number of out-going edges and the number of in-coming
edges of v, denoted as d+ðvÞ and dðvÞ, respectively.
Definition
An ASM is an induced subgraph
HðtsH,teHÞ ¼< VH,EH,tsH,teH > of G with a distinguished
node tsH not in H as the entry and a distinguished node
teH not inH as the exit satisfying the following conditions:
(1) ‘Single entry’: all edges from (G–H) to H come from
tsH;
(2) ‘Single exit’: all edges from H to (G–H) go to teH;
(3) ‘Alternative paths’: d+ðtsHÞ > 1 and d
ðteHÞ > 1;
(4) ‘Minimal’: there does not exist a vertex v 2 VH, such
that v post-dominates tsH or pre-dominates teH in
HðtsH,teHÞ.
Having an ASM being single entry and single exit
makes it an independent observation of the transcriptome.
The number of transcript copies that go through an ASM
can be entirely determined by the number of transcript
copies passing through the entry node and exit node.
There does not exist additional flow of transcripts. This
property allows robust local abundance estimation within
each ASM.
One ASM might be ‘nested’ within another ASM if it is
a subgraph of the bigger one. For two distinct ASMs
H1 ts1,te1ð Þ and H2 ts2,te2ð Þ,H2 is nested in H1 if and only
if ts1 pre-dominates ts2 and te1 post-dominates te2. If there
exists no H3, such that H2 is nested in H3 and H3is nested
inH1, we sayH2 is a ‘child’ ofH1, andH1 is the ‘parent’ of
H2. An example is shown in Supplementary Figure S1. In
this case, we can derive a hierarchy of nested ASMs. In the
resulting hierarchy, if H1 is an ancestor of H2 (i.e. H2 is
nested in H1), the transcripts flowing into H2 must be a
subset of the transcripts in H1. IfH1 andH2 have the same
parent (i.e. H1 and H2 are siblings) and are on the same
path, the transcripts passing through H1 and H2 are the
same, and the expected expression of H1 and H2 are the
same.
Here, we outline the algorithm that decomposes an ESG
G ¼< V,E,ts,te,w > into a set of ASMs. The pseudo-code
can be found in Supplementary Section S1. Steps 1 and 2
describe the procedure to determine ASMs within an
ASM-type subgraph, and Step 3 decomposes the
subgraph, which allows the iterative identification of all
ASMs in the gene. To initialize, we start with the entire
ESG G.
Step 1. Calculate the immediate pre/post-dominators
We first calculate the immediate pre-dominators
and post-dominators of every vertex v 2 V. The pre-
dominators for vertex v (other than v) can be found by
iteratively intersecting the sets of pre-dominators for all
predecessors of v (26,27). Similarly, the set of post-
dominators for v is the union of v and the intersection
over the sets of post-dominators for all successors of v.
According to the approach proposed in (28), the bottom
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nodes of the depth-first search tree of G are grouped a
collection of small vertex-disjoint regions called
‘microtrees’. For vertex v, the aforementioned union-
intersection operations are then performed locally within
the microtree, where the immediate dominator of v resides.
Step 2. Discover ASM
Candidate entries or exits for ASMs are the vertices with
out-degree or in-degree >1. Let u and v be two vertices in
V, such that d+ uð Þ > 1 and d vð Þ > 1. If u pre-dominates v
and v post-dominates u and there does not exist a third
vertex w 2 V, such that u pre-dominates w and
v post-dominates w, the subgraph bounded by u and v,
denoted as H(u, v), forms an ASM.
Step 3. Discover nested ASM
For any two edges (u, v) and ðu0,v0Þ. We order ðu,vÞ > ðu0,v0Þ
if and only if there exists a directed path from u to u0 and a
directed path from v0 to v. Hence, the edges in H form a
partial order. If there is no edge ðu00,v00Þ in H, such that
ðu00,v00Þ > ðu,vÞ, edge (u, v) is called a maximal edge. We
remove all the maximal edges in H and iteratively go to
Step 1 to resolve all nested ASMs until no new ASMs can
be found in Step 2.
The time complexity of the first step is linear in the
number of vertices and edges (28), or O(jVj+jE). In the
second step, for every candidate entry, the search of its
paired ASM exit checks whether its immediate
post-dominator is a candidate exit and also immediately
pre-dominated by the entry, taking time of OðjVjÞ. In the
last step, the maximal edges according to the partial order
can be selected by iterating over all edges in E and keeping
track of the maximal edges, resulting in an O(jcj+jE) time
scheme. Here c denotes the number of maximal edges
in G. Because c is typically small in a splice graph, the
time complexity of the third step can be viewed as
O(jEj) in our application. Therefore, the time complexity
of identifying ASMs from an ESG G is O(jVj+jE), and the
time for discovering all nested ASMs is dependent of the
total number of ASMs.
Abundance estimation for alternative ASM paths
Next, we estimate the number of transcript copies that
flow through each splice path in the ASM for each indi-
vidual sample. Specifically, for every ASM, we estimate
the relative proportion and the expression level of its al-
ternative paths in each sample. Typical Poisson-based
methods such as (29,30) collect the number of reads
falling on each exon as observations. Because only the
starting position of each read contributes to
the observed counts, these methods ignore the information
encoded in the rest of the nucleotides such as the coverage
of splice junction. The counting approach makes it infeas-
ible to incorporate spliced reads in the model for better
estimation. DiffSplice proposes a generalized model that
takes into account the observed support on splice
junctions in addition to exon expression to estimate the
abundance of alternative paths. Such consideration is
crucial for estimating alternative transcription paths, as
alternative splice junctions differentiate the isoforms.
Preliminaries
The notations used in the abundance estimation procedure
are summarized in Table 1. Given a transcript t and the
reads from one sample, let cti be the number of reads
covering the ith nucleotide in t. We define the read
coverage on t as the averaged number of reads covering
each base in the transcript, Ct ¼
1
lt
Plt
i¼1 c
t
i , where lt denotes
the exonic length of t. Then, Ct is an estimator for the
number of transcript copies in the sample, which
provides a direct measure for the expression level of the
transcript t. Similarly, we define the read coverage on
an exonic segment e with exonic length of le
as Ce ¼
1
le
Ple
i¼1 c
e
i , and we use Cj to denote the number
of spliced reads that pass a splice junction j. The
read coverage Ce provides an estimator for the number
of transcript copies that flow through the exonic
segment e. The number of spliced read alignments Cj con-
stitutes an estimator for the number of transcript copies
that pass from the donor exon to the acceptor exon con-
nected by the junction j. Therefore, we calculate the
observed read coverage for every exon and the observed
number of spliced read for every junction and derive an
estimator for transcript coverage based on the
observations.
The normal model for the observed read coverage
We now demonstrate a model where read coverage will be
used as the observed variables for abundance estimation.
Assume the sequencing procedure as a random sampling
process, in which every read is sampled independently and
uniformly from every possible nucleotide in the transcripts
(29). For a single transcript t in an ASM, the probability
that a read from t falls in e is pejt ¼
le
lt
. Given Ntthe total
number of reads from t, the number of reads falling in
segment e Nejt, follows a binomial distribution with
Table 1. Notations in the abundance estimation for alternative ASM paths
Symbol Meaning Symbol Meaning
r The length of a read Ce The read coverage exonic segment e
t An alternative transcription path Cejt The read coverage on exonic segment e from transcript t
e An exonic segment At,e A Boolean variable (1 or 0) indicating whether t includes e
 An ASM m The total number of exonic segments and splice junctions in 
lt The exonic length of t n The number of alternative transcription paths in 
le The exonic length of e N The total number of reads in 
Nt The number of reads from path t q The relative proportion of the alternative paths in 
Nejt The number of reads on e from t  The estimated expression for an alternative path or an ASM
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parameters Nt and pejt,Nejt  BinðNt,pejtÞ. When Nt is suf-
ficiently large, the binomial distribution can be well
approximated using a normal distribution with mean
Ntpejt and variance Ntpejtð1 pejtÞ, written as
Nejt _NðNtpejt,Ntpejtð1 pejtÞÞ. Let r denote the length of
a read. The value of
Nejtr
le
represents the read coverage on
e contributed by t, Cejt, whereas the value of
Ntr
lt
represents
the read coverage on t, Ct. Therefore, we have
Nejtr
le
_Nð
Ntpejtr
le
, r
2
l2e
Ntpejtð1 pejtÞÞ, equivalently and
Cejt _NðCt,
rðlt  leÞCt
ltle
Þ: ð1Þ
For a splice junction j, its length lj is defined to equal the
read length r, which is the length of the exonic region,
where reads starting in this region can cover the splice
junction. The number of spliced reads from t that covers
j, Cjjt still follows the normal distribution in Equation (1).
From Equation (1), Cejt and Cjjt are unbiased for Ct.
The variance of Cejt varies according to the coverage Ct
and the segment length le. Dividing the difference between
Cejt and Ct by Ct, we have the ratio
CejtCt
Ct
following a
normal distribution Nð0, rðltleÞCtltle Þ. Higher coverage and
longer segments lead to estimators with smaller variance
of the relative deviation from the true transcript coverage,
which we demonstrate in the simulated results (Figure 3).
Estimation of alternative ASM path abundance
Consider an ASM  with totally m exonic segments and
splice junctions. Assume  consists of n alternative tran-
scription paths. The exonic length of a path t is hence
given as lt ¼
Pm
i¼1 At,ili, where At,i ¼ 1 if path t covers
the ith exonic segment and At,i ¼ 0 otherwise. Let
q ¼ fq1,q2,    ,qng denote the relative proportions of the
alternative paths, with
Pn
i¼1 qi ¼ 1. The probability of a
read falling into path t is then written as pt ¼
qtltPn
i¼1
qili
,
with
Pn
i¼1 pi ¼ 1. Assume the number of reads sampled
from  follows a Poisson distribution with parameter
N, where N represents the expression of  in the sample
accounting for the depth of sequencing and the length of
(a) (b)
(c) (d)
Figure 3. Evaluation of DiffSplice on simulated data set under different sampling depth. (a) Scatterplot of profile JSD and DiffSplice JSD at
different sampling depth. (b) JSD correlation and MSE of path distribution at different sampling depth (from 10 to 100%). (c) MSE of path
distribution grouped by different expression quartile. (d) MSE of path distribution grouped by different discriminative length quartile. Within each
quartile group, the box plot of the MSE is plotted for every read set (from left to right: the read sets with sampling depth percentile of 10 through
100%).
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 (29). The number of reads sampled from path t, Nt then
follows a Poisson distribution with parameter Nt, i.e.
Nt  PoissonðNt Þ: ð2Þ
We hence derive the maximum likelihood estimators for
the path proportion, q, and the expected total number of
reads in , N. With observed read coverage C1,C2,    ,Cm
on every exonic segment and splice junction, the likeli-
hood of q and N is the joint density of C1 through Cm
under q and N,
Lðq,NjdataÞ ¼ Lðq,NjC1,    ,CmÞ ¼ PðC1,    ,Cmjq,NÞ
We assume that C1,C2,    ,Cm are mutually independ-
ent. The likelihood function can be factorized as:
Lðq,NjC1,    ,CmÞ ¼
Yn
t¼1
Ym
i¼1
fðCijtjNtÞgðNtÞ, ð3Þ
where fðÞ is the density of the exonic/junction coverage
distribution in Equation(1), and gðÞ is the density of the
transcript read count distribution in Equation (2). We
then use the expectation maximization algorithm to
derive the maximum likelihood estimators for q and
N (Supplementary Section S2). In addition to estimating
transcription path proportions, the expectation maximiza-
tion algorithm also calculates the expected expression of
each transcription path, 1,2,   n. Then, the expected
expression of  sums up the expected expression of all
transcription paths in , ¼
Pn
t¼1 t, forming an esti-
mator for the total number of transcript copies passing
through .
Estimation of gene expression
Within a gene G, the abundance estimation procedure
starts from the minimal ASMs, i.e. the ASMs in the
bottom level of the decomposition hierarchy, then propa-
gates toward the top of the hierarchy. During inference
within an ASM , all ASMs nested in  must have per-
formed the alternative path abundance estimation and
hence are treated as single exonic segments, using their
estimated expression as the exonic coverage. The estima-
tor for the expression of gene G, G is hence the mean
expression of all the exonic segments and ASMs that
directly constitute G (or in the decomposition hierarchy
all the children of G on the first level). This estimator
provides a direct measure for the expected total number
of transcript copies in gene G in the RNA-seq sample.
Statistical test for differential transcription
Differential expression under different conditions may
exhibit in two aspects. At the gene level, the difference
in a gene’s expression level measures the change of the
total expression of all the transcripts in this gene (‘differ-
ential gene expression level’). At the transcript level, the
difference in the relative proportion of alternative tran-
scription paths reflects the regulation on the expression
of individual transcripts (‘differential gene transcription’).
In DiffSplice, we test the two levels of differences separ-
ately. Based on the estimators for gene expression level
derived in the previous section, we use the same method
as proposed in Significance Analysis of Microarrays
(SAM) (31) to test for difference in gene expression
under different conditions (groups). Then, we extend the
method to test for difference in transcription by defining
test statistic in terms of divergence between relative ex-
pression profiles of alternative paths.
Test statistic for differential gene transcription
The transcript-level expression of a gene is characterized
by the relative proportion of the alternative transcription
paths in every ASM of this gene. Let S1 ¼ fs11,s12,    ,s1n1g
and S2 ¼ fs21,s22,    ,s2n2g denote two groups of samples.
Let Q1 ¼ fq11,q12,    ,q1n1g and Q2 ¼ fq21,q22,    ,q2n2g
denote the estimated path proportion of an ASM  in
each sample. Let q1 ¼
1
n1
Pn1
i¼1 q1i and q2 ¼
1
n2
Pn2
i¼1 q2i
denote the mean distributions of the two sample groups.
To select significant differences in transcription, we look
for ASMs with significant difference in path distributions
between the two groups but consistent path distributions
within each group. We use the square root of the Jensen–
Shannon divergence (JSD) (32) to quantitate the dissimi-
larity between two distributions as a real value between
0 and 1 (Supplementary Section S3). We define the
between-group difference as the divergence between the
group mean distributions,
x ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
JSDðq1jjq2Þ
p
: ð4Þ
The within-group variance of each group is defined as:
s ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
c½
Xn1
j¼1
JSDðq1jjjq1Þ+
Xn2
j¼1
JSDðq2jjjq2Þ
vuut , ð5Þ
where c ¼ n1+n2n1n2ðn1+n22Þ is the normalization constant.
Abundance estimation on ASMs with low expression
often associates with higher unstability. Therefore, we
add  as a penalty for low expression, based on a
logistic function of the averaged estimated expression of
the ASM ,
 ¼ ð2
2
1+e
Þ  smax, for  0, ð6Þ
where  adjusts the penalized expression range of low
ASM expression (e.g.  ¼ 1 for penalizing ASMs with
estimated expression <6 while assigning negligible
penalty to ASMs with higher expression) and smax
denotes the largest variance among all ASMs in the data.
Therefore, the relative difference in transcription of an
ASM  is in the form:
d ¼
x
s+
, ð7Þ
measuring the extent how the distributions over alterna-
tive paths within the ASM consistently differ between the
two groups.
Permutation test
An empirical distribution of relative difference can be
obtained by calculating test statistics after permuting
samples across groups (31). Suppose totally M ASMs
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are tested for differential transcription. The relative tran-
scriptional difference is calculated for every ASM, and the
order statistics are collected, dð1Þ  dð2Þ      dðMÞ.
Under each permutation p, order statistics of relative dif-
ferences could also be calculated in the same way:
d
p
ð1Þ  d
p
ð2Þ      d
p
ðMÞ. Averaging order statistics from
all permutations, we have the expected relative difference
in transcription: dðiÞ ¼
1
jPj
P
p2P d
p
ðiÞ for 1  i M, where P
is the set of all permutations and jPj is the number of
permutations.
Statistical significance
Significant changes on transcription are concluded based
on the extent of disagreement between calculated and
expected test statistics. Given a threshold trans, an ASM
with relative transcription difference of dðiÞ is accepted to
have significant difference on transcription, if
jdðiÞ  d

ðiÞj > trans. The choice of trans is monitored by its
associated FDR, which we define next.
False discovery rate
At a cutoff of trans, the quantity of falsely discovered
ASMs in each permutation is estimated as the number
of ASMs, such that jd
p
ðiÞ 
dðiÞj > trans. The FDR for dif-
ferential transcription is hence estimated as the averaged
number of falsely discovered ASMs over all permutations,
divided by the total number of ASMs.
RESULTS
Experimental results with simulated data sets
The following set of experiments first evaluated the
accuracy of DiffSplice on data sets simulated on the
entire human transcriptome with varying sampling depth
and varying degrees of 50 or 30 positional bias. We then
compared DiffSplice with the state-of-the art methods,
including Cufflinks and FDM, on the simulated data set
used by Singh et al. (13).
Simulation of RNA-seq data sets
We developed an in-house simulator to generate two
RNA-seq data sets on human transcriptome. In each
data set, we generated pairs of RNA-seq samples under
various sampling depth or sampling bias. For every
sample, the simulator randomly generates relative expres-
sion profiles for the transcripts, based on the user-
provided human transcriptome annotation. A number of
complementary DNA (cDNA) molecules are then
assigned to every transcript according to its expression
level and the size of the data set. A cDNA library is
hence constructed through steps as amplification and
size selection, and RNA-seq reads are sampled from the
cDNA library.
For every pair of samples, we first calculate their tran-
scriptional difference at each ASM based on the transcript
annotation and expression profiles used in generating the
RNA-seq data, referred to as the ‘profile JSD’. The dif-
ference in ASM estimated by DiffSplice directly from the
RNA-seq reads is referred to as the ‘DiffSplice JSD’. The
profile JSD reflects the ground truth difference in each
ASM, whereas the DiffSplice JSD is an estimation from
sampled reads. We calculate the Pearson correlation
between the two as a measure for the accuracy of the
estimated difference, denoted by the ‘JSD correlation’.
We also consider a complementary measure for every
ASM, the mean squared error (MSE), which calculates
the error of the estimated path distribution from the dis-
tribution in the expression profile. We average the MSE
from both samples in a pair-wise comparison, which is
denoted as the ‘MSE of path distribution’.
Human transcriptome under varying sampling depth
We first study the effect of the sampling depth on the
abundance estimation. We simulated 10 pairs of samples
on human transcriptome, from 10M (10%) reads to
100M (100%) reads. For each sample, 2	 75 bp PER
with average insert size of 100 bp were generated. Genes
with averaged read coverage per base >10 were picked to
compare the difference by profile and the difference
derived by DiffSplice. Figure 3a shows the scatterplots
of profile JSD against JSD estimated by ASM in read
sets of 10M (10%), 40M (40%), 70M (70%) and 100M
(100%) reads. The data with relatively lower sampling
depth (e.g. depth=10%) show less points than the data
with higher sampling depth because it covers less ASMs.
However, all sets have most points close to the diagonal,
indicating minimal deviation between profile JSD and
estimated JSD. The correlations range from 0.85 to 0.88
(Figure 3b). Higher JSD correlation is achieved by
increasing the sampling depth, while the MSE of path
distribution also decreases. Figure 3c separates all ASMs
into four quartile groups according to their expression
level and compares the distribution of MSE in each
group. ASMs with higher expression separate randomness
of read sampling and result in more stable estimates. As
expected, the upper two quartiles exhibit better estimates
than the lower two quartiles, in terms of both smaller
mean and lower variance.
Besides the expression of the ASMs, the variance of the
abundance estimator is also related to the ‘discriminative
length’, the length of the exonic regions that are specific to
a path in an ASM. Figure 3d groups all ASMs into four
quartiles according to the discriminative length. ASMs
with larger discriminative length are also expected to be
more robust to random sampling errors and have higher
accuracy on discriminating difference between path distri-
butions. The lowest quartile has slightly higher MSE than
the rest 75% ASMs. In contrast, the MSE sharply de-
creases in all groups, emphasizing the impact of
sampling depth over discriminative length in improving
abundance estimation accuracy.
Human transcriptome under varying sampling bias
Methods that estimate transcript abundance are typically
designed under the assumption that the RNA-seq frag-
ments are sampled independently, and the sampling
position is uniformly distributed along the transcript
from which the fragments originate. The transcript infer-
ence and thereafter the evaluation of differential expres-
sion may be altered if sampling bias is introduced by
sample preparation protocols. Two types of sampling
bias are commonly observed in RNA-seq data, namely,
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position-specific bias and sequence-specific bias
(30,33–35).
We specifically looked at 30 bias that is a typical
position-specific bias. To simulate the data, we introduce
a parameter b to represent the degree of sampling bias,
such that 1+ equals to the ratio of the sampling
probability at the last base in the 30-end of a transcript
over the sampling probability at the first base in the 50 end
of the transcript. The sampling probability at a middle
bases t is then calculated as a linear interpolation,
Probt ¼ Prob50  ð1+t=lÞ, where lt denotes the distance
from the base t to the 50 end of the transcript, and
l denotes the length of the transcript.
We simulated 11 read sets on human transcriptome
under  from 0 to 2.0. Figure 4a shows the scatterplots
of the profile JSD against the DiffSplice JSD in read sets
under no bias and bias of 0.6, 1.2 and 1.8. All sets have
most estimated JSD close to profile JSD, with no signifi-
cant effect of sampling bias. This is consistent with
Figure 4b, where the correlations range from 0.878 to
0.887. The MSE is slightly lower when no bias is
introduced but remains roughly unchanged as  increases,
indicating the robustness against altered sampling distri-
bution of the alternative path estimation by DiffSplice. In
Figure 4c and d, ASMs are again grouped into quartile
groups according to their expression level and discrimina-
tive length. Although the expression level still dominates
the accuracy of path abundance estimation, no significant
effect of sampling bias is observed in all groups.
Differential transcription between two groups of samples
We further applied our method to the two simulated data
sets used in the evaluation of FDM (13). More than 2100
genes with at least two transcripts were simulated in the
two tissues, each tissue having four replicates. The square
root of the JSD between transcript profiles of the two
tissues was calculated for each gene to suggest the ‘true’
transcriptional difference. The coverage of each gene was
calculated to measure the expression level. Genes with
coverage >1 were chosen for comparison. In addition to
DiffSplice, three other methods (FDM, Cuffdiff with
annotation and Cuffdiff without annotation) were also
(a) (b)
(c) (d)
Figure 4. Evaluation of DiffSplice on simulated data set in the presence of position-specific sampling bias. (a) Scatterplot of profile JSD and
DiffSplice JSD at different b. (b) JSD correlation and MSE of path distribution at different b (from 0 to 2). (c) MSE of path distribution
grouped by different expression quartile. (d) MSE of path distribution grouped by different discriminative length quartile. Within each quartile
group, the box plot of the MSE is plotted for every read set (from left to right: the read sets with b of 0 through 2).
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applied on this data set. FDM was run using no transcrip-
tome annotation information. With FDR <0.01,
DiffSplice reported 887 genes with significant difference
on transcription. At confidence level of 0.05, FDM,
Cuffdiff with annotation and Cuffdiff without annotation
reported 722, 931 and 530 differentially transcribed genes,
respectively.
Figure 5a–d plot the genes coordinated by the square
root of its profile JSD and the logarithm of its coverage.
The genes with significant differences on transcription
identified by each method are represented by red dots.
The genes with insignificant differences are represented
by blue circles. Along the x-axis, the majority of the
significantly differentiated genes identified by DiffSplice
have large profile JSD (square root of profile JSD> 0.2),
showing that DiffSplice correctly captures transcriptional
divergences between the two tissues. Along the y-axis, the
most significant genes identified by DiffSplice have rela-
tively high coverage. This follows the fact that differences
present in highly expressed genes are less likely to occur
randomly or be introduced by sampling error and hence
have higher confidence. We calculate the sensitivity of all
four methods at genes that have large profile difference, as
well as high expression, for example, the region with
square root of profile JSD >0.25 and coverage >5.
Among the 548 genes in that region (the up-right part),
DiffSplice identified 506 genes as significant differences,
with a sensitivity of 92% (506 of 548). This sensitivity is
10 percentage points higher than those of FDM (80% or
437 of 548) and Cuffdiff with annotation (81% or 443 of
548), and 30 percentage points higher than that of Cuffdiff
without annotation (58% or 316 of 548). To assess the rate
of false positives, we further calculate the precision for
every method, defined as the proportion of the true sig-
nificant genes called by each method in all the significant
genes called by the method. The precision of DiffSplice
(57%) is close to those of FDM (61%) and Cuffdiff
without annotation (60%) and is 9 percentage points
higher than that of Cuffdiff with annotation (48%).
The test statistic of DiffSplice also takes into account
the variance of alternative path distributions among the
replicates in each group. Figure 5e–h plot the genes
coordinated by the square root of its profile JSD and
the within-tissue variance of its transcript profile. The
genes with significant or insignificant differences are still
represented by red dots and blue circles, respectively.
Almost all significant genes identified by DiffSplice have
low profile variance compared with profile divergence. We
also calculate the sensitivity of all four methods at genes
that have large profile difference, as well as small
within-tissue variance, for example, the region with
square root of profile JSD> 0.25 and variance <0.1.
Among the 952 genes in that region (the bottom-right
part), DiffSplice identified 849 genes as significant differ-
ences, with a sensitivity of 89% (849 of 952). This sensi-
tivity is 15 percentage points higher than that of FDM
(74% or 705 of 952), nearly 10 percentage points higher
than Cuffdiff with annotation (80% or 764 of 952), and 40
percentage points higher than that of Cuffdiff without an-
notation (49% or 462 of 952). DiffSplice also has a
(a) (b) (c) (d)
(e) (f) (g) (h)
Figure 5. Comparison among DiffSplice, FDM, and Cufflinks on simulated data set of human transcriptome. (a–d) Scatterplot of coverage against
profile JSD for results of (a) DiffSplice, (b) FDM, (c) Cufflinks with annotation and (d) Cufflinks without annotation, respectively. The majority of
the differentially transcribed genes identified by DiffSplice (plotted as red dots) have square root of profile JSD> 0.2 and log coverage >0.5. Setting
the genes with square root of profile JSD> 0.25 and coverage >5 to have significant difference in profile, DiffSplice achieves a sensitivity of 92%,
higher than those of FDM (80%), Cuffdiff with annotation (81%) and Cuffdiff without annotation (58%). (e–h) Scatterplot of variance against
profile JSD for results of (e) DiffSplice, (f) FDM, (g) Cufflinks with annotation and (h) Cufflinks without annotation, respectively. Most of the
differentially transcribed genes identified by DiffSplice (plotted as red dots) have variance <0.1. Setting the genes with square root of profile
JSD> 0.25 and variance <0.1 to have significant difference in profile, DiffSplice reaches a sensitivity of 89%, higher than those of FDM (74%),
Cuffdiff with annotation (80%) and Cuffdiff without annotation (40%).
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precision (96%) close to FDM (98%) and clearly higher
than Cuffdiff with annotation (82%) and Cuffdiff without
annotation (87%).
Experimental results with real data sets
Lung differentiation data set
The human lung airway epithelium lies on the lung–envir-
onment interphase, serving as the important physical
barrier against invading pathogens. It is composed of
various cell types, including ciliated cells, mucus-secretory
goblet cells and basal cells, differentiated from specialized
cells in varying numbers. We hypothesized that genes
expression changes, including the differential expression
of alternative spliced isoforms, are key in the mucociliary
cell differentiation and function. Thus, we have sequenced
mRNAs from primary human bronchial cells at the early
(Day 3) and late (Day 35) differentiation stages, respect-
ively, by high-throughput sequencing. Three biological
replicates were used in each group (Day 3 versus Day
35). Following the manufacturer’s instruction, mRNA
libraries were made for each sample, and 28 million
76-bp single-end reads were generated from each sample
for analysis. The biological findings from this experiment
will be presented in another report.
The RNA-seq reads were mapped by MapSplice 1.15.1
(18) to the human reference genome (hg19). About 94%
were mapped for each sample. DiffSplice was then per-
formed on these read alignments. Cufflinks+Cuffdiff
pipeline (version 1.1.0 with bias correction) was also run
on the same read alignments with results both using and
not using transcriptome annotation generated for
comparison.
As shown in Figure 6a, DiffSplice identified 2077 genes
that have differential gene expression level between Day
3 and Day 35 at FDR< 0.01 and requiring the fold change
of >2 (up-regulated) or <12 (down-regulated). This number
is similar to the results obtained from the SAM analysis
(31). At Day 35, 1429 genes were tested to have signifi-
cantly higher expression level than at Day 3, whereas 648
genes were tested to have significantly lower expression
level than at Day 3. This observation has indicated
active metabolism biogenesis process occurring during
the airway epithelium differentiation. At FDR< 0.01,
(c)
(a) (e)
(d)
(b)
Figure 6. Comparison between DiffSplice and Cufflinks on the lung differentiation data set. (a) Differential expression discovered by DiffSplice
using MapSplice alignment without annotation. (b) Comparison among differentially transcribed genes discovered by DiffSplice, Cufflinks with
annotation and Cufflinks without annotation. (c) Percentage of significant genes with differential transcription against number of transcripts.
(d) Number of significant genes with differential transcription against percentage of samples with gene coverage <3 in each group.
(e) Differential transcription in gene PI4KB, identified by DiffSplice but missed by Cufflinks without annotation.
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DiffSplice also identified 498 genes exhibiting significant
differentiation on alternative transcription. Among them,
109 genes had significantly altered overall gene expression,
whereas the rest 389 genes were differentially transcribed
while their total gene expression remains at the same
level. We randomly selected genes with the inter-group
square root of JSD> 0.3 for qRT-PCR validation
(Supplementary Figure S6). The expression profiles of
two validated genes TMC5 and LMO7 are included in
Figure 7 and Supplementary Figure S7.
We compared the differentially transcribed genes
identified by DiffSplice and Cufflinks+Cuffdiff.
Cufflinks+Cuffdiff with annotation reported >7000
genes that have significant differential transcription
events between Day 3 and Day 35, whereas
Cufflinks+Cuffdiff without annotation only reported
3000 genes. In comparison, DiffSplice reported 498
genes with 77 and 54% overlapped with results of
Cufflinks+Cuffdiff with and without annotation, respect-
ively. The result is shown as Venn diagram in Figure 6b.
Next, we detail the major issues from the investigation of
the discrepancy.
Effect of transcription complexity. In general, genes with
larger number of isoforms tend to have more splicing
events, and therefore have a higher chance to be differen-
tially transcribed. Nevertheless, having the majority of the
genes detected to be significantly different indicates a high
level of false positive discovery rate. In Figure 6c, we
divided genes into groups according to the number of
isoforms and plotted the percentage of genes detected to
be significant as a function of the number of isoforms.
As high as 80% of genes with more than five isoforms
were identified as having significant differential transcrip-
tion by Cufflinks+Cuffdiff with annotation, and
50–75% of genes with more than five known isoforms
were identified as significant by Cufflinks+Cuffdiff
without annotation. The decreased number of significance
called by Cuffdiff without annotation correlates with the
typically lesser number of reconstructed transcripts in a
gene than the number of annotated transcripts. In
contrast, the percentage of genes detected to be differen-
tially transcribed is typically <10% with DiffSplice, with a
trend of raising percentage as transcriptome complexity
increases.
Transcripts in genes with high transcription complexity
are difficult to infer and quantify, requiring a high read
coverage to be reliable. Inaccurate transcript inference
and/or quantification may not only lead to false positive
discovery of the differentially transcribed genes but also
may miss genes that are truly differentially transcribed. In
gene PI4KB, DiffSplice discovered two ASMs, as shown
in Figure 6e. The first ASM starts from the fourth exon
(from the 50 end) and ends at the sixth exon, alternatively
excluding or including the fifth exon. The second ASM
spans from the first exons to the fourth exon, alternatively
transcribing the second and the third exon. The first ASM
was tested to have significant difference in transcription by
DiffSplice, which had significantly higher exon-skipping
ratios at Day 3. Without annotation, Cufflinks failed to
point out this difference. Cufflinks took the combination
of the two alternative splicing events and assembled seven
transcripts, containing three spurious transcripts
compared with RefSeq annotation. In addition to the
inconsistency in assembled transcripts, the estimated tran-
script abundance by Cufflinks did not reflect the shift on
expression. Combining the transcripts that included the
fifth exon (TCONS_00003827, 00003831 and 00003833),
the total expression of the three transcripts was 8.63 at
Day 3 and 9.27 at Day 35 [in (Reads Per Kilobase per
Million mapped reads (RPKM)], which did not match
the observed increase on the expression of the fifth exon.
Also, the overall expression of all the seven assembled
transcripts fell from 18.8 (Day 3) to 16.6 (Day 35),
which did not match the observation that the overall ex-
pression was actually higher in Day 35. In gene TMC5,
DiffSplice discovered an alternative transcription start
event with four alternative start sites and an exon-
skipping event (Figure 7). The alternative start event was
tested to have significantly higher abundance of the path
ASM1.path4 at Day 35 (48.9%) than Day 3 (14.7%). This
finding was consistent with the result of qRT-PCR experi-
ment that the alternative start site corresponding to
ASM1.path4 had its abundance at Day 35 at least twice
as high as its abundance at Day 3. This gene was also
found having differential expression level, with its expres-
sion at Day 35 >10 times higher than that at Day 3.
Effect of coverage and variance in replicates. When
determining differential transcription, read coverage
needs to be sufficiently high to make a reliable inference
on the transcript expression. In Figure 6d, we plot the
number of genes that were called to be significantly
Figure 7. Alternative transcription start sites identified by DiffSplice in
gene TMC5. The relative expression of isoform passing ASM1.path4
increased significantly from Day 3 to Day 35. The change has been
validated by qRT-PCR experiment (Supplementary Figure S6).
Meanwhile, the overall gene expression level also significantly increased
with a fold change of 11.
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different in transcription against the number of samples
with exceptionally low expression (e.g. gene coverage <3).
The three methods in comparison detect similar percent-
age of significant genes when the majority of the samples
are well expressed. However, Cufflinks+Cuffdiff calls
hundreds of genes as significantly differentiated when
almost all samples in a group are barely expressed at all.
Besides, Figure 6d also indirectly shows high
within-group variance among replicates. In testing of
differential expressed or transcribed genes, the variance
among samples within the same group is expected to
be low and should be well controlled. More than three
of nine replicates in one of the comparison groups had
extremely low coverage in 269 genes detected by
Cufflinks+Cuffdiff with annotation and 128 genes
detected by Cufflinks+Cuffdiff without annotation,
demonstrating high within-group variance of these genes.
Novel alternative splicing. As DiffSplice takes only
RNA-seq read alignments as input and relies on no anno-
tation, it captures splicing events that are only relevant to
the given mRNA samples and has the capability of dis-
covering novel alternative transcripts. We categorize an
ASM detected by DiffSplice into four types: the ASM
exactly matches an annotated ASM; the ASM is a
subgraph of an annotated ASM; the ASM partially
overlaps with an annotated ASM and the ASM is not
found in the annotation. The histogram of each category
at varying coverage is shown in Figure 8a. The ASMs
detected by DiffSplice show high consistency with those
generated from known annotation. Among the 5556
ASMs found be DiffSplice, 2426 ASMs matched an
annotated ASM, and 2219 ASMs were subsets of
annotated ASMs. Besides the alternative splicing events
present in annotation, we found 174 ASMs with novel
paths added to annotated ASMs and 736 novel ASMs.
For example, we discovered a novel exon in gene
STRA13, located between the second and the third exon
in the RefSeq annotation (Figure 8b). This exon was dis-
covered as differentially skipped between Day 3 (50%
skipping ratio) and Day 35 (30% skipping ratio).
Because the exon-skipping event in STRA13 is not
present in the transcriptome annotation, Cufflinks with
annotation did not capture the difference. Cufflinks
without annotation falsely initiated a transcript from the
third annotated exon and did not detect the event either.
Breast cancer data set
We further applied DiffSplice to the RNA-seq data sets
generated from two breast cancer cell lines, MCF7 and
SUM102 (13). Each cell line group comprises of four tech-
nical replicates, and 80 million 100-bp single-ended
reads were sequenced for each replicate. FDM was origin-
ally applied to these data sets to detect genes that might
have differentially transcribed without usage of transcrip-
tome annotation information (13). At FDR< 0.01,
DiffSplice identified 6103 genes with significant difference
on expression level and 2507 genes with significant differ-
ence on transcription between the two cell lines, including
1353 genes with both differences. For genes that were
differentially transcribed, DiffSplice had 955 (38.1%)
shared with those discovered by FDM (Supplementary
Section S6.3).
DiffSplice successfully identified the two genes CD46
(Figure 9a) and NPC2 (Figure 9b) that were originally
validated by qRT-PCR in FDM article. However, unlike
FDM, DiffSplice directly pinpoints the location of alter-
native splicing events that are differentially expressed,
consistently with those chosen for the qRT-PCR
validation. For example, in the exon-skipping event
found in CD46 (Figure 9a), the averaged estimated pro-
portion of the path that included the 13th exon
(chromosome1:207963598–207963690) was 34.7% in the
(a)
(b)
Figure 8. DiffSplice discovers alternative splicing variants present in
the data. (a) Number of ASMs discovered by DiffSplice at different
expression level. Besides 2400 ASMs that exactly match annotated
ASMs, DiffSplice discovered >2000 ASMs, where only subsets of
annotated splicing variants were present, nearly 200 ASMs with novel
splicing variants added to annotated alternative splicing events and
>700 ASMs that were completely new to the annotation. (b) Novel
alternative splicing in gene STRA13, identified by DiffSplice but
missed by Cufflinks both with and without annotation. DiffSplice dis-
covered a novel exon in the annotated intron region between the second
and the third exon of STRA13. Splice junctions evidenced that the exon
was alternatively excluded (path 1) or included (path 2) in transcripts of
this gene, and the skipping ratio was tested to have significantly
decreased from Day 3 to Day 35.
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SUM102 group and 13.9% in the MCF7 group. This
result was consistent with the observation in the
qRT-PCR experiment that the skipped exon had >2-fold
higher expression level in SUM102 than in MCF7. In gene
NPC2, DiffSplice discovered two alternative splicing
events, one nested within the other (Figure 9b). The
intron retention occurs between the last two exons was
found present primarily only in MCF7 samples. This
ASM was further nested in a larger exon-skipping event
spanning the last three exons, where the second exon was
alternatively spliced with a significantly lower skipping
ratio in SUM102 samples. The first intron-retention
event was picked for qRT-PCR validation. The averaged
estimated proportion of the path that retained the intron
(chromosome14:74946992–74947388) was 0.5% in the
SUM102 group and 17.9% in the MCF7 group, consistent
with the experimental observation that the retained intron
had at least 10-fold higher expression level in MCF7 than
in SUM102.
Besides alternatives spliced events, DiffSplice can be
generalized to detect structural variations whose
presence is different across two comparison groups.
Forty-two genes were detected to have a small insertion/
deletion that varies between MCF7 and SUM102. As
shown in Figure 10, a 19-bp novel deletion was discovered
in the last exon of gene REEP4. The averaged estimated
proportion of the path that included the deletion was
>99.2% in SUM102 samples. The estimated proportion
of the deletion fell to 49.9% as turning to MCF7 group.
We directly resequenced the genomic DNA and the cDNA
derived from the mRNA of the cell lines and validated this
novel deletion. These deletions evidenced the genomic
variation present in cancer cell lines and may contribute
to prognostic differences together with other differential
expression events.
DISCUSSION
We present an ab initio method for the detection of alter-
native splicing isoforms that are differentially expressed
under different conditions using high-throughput
RNA-seq reads. Our approach does not rely on the infor-
mation of full-length transcripts of any sort, either from
annotation or from computational inference. Instead, the
information carried by the RNA-seq read alignment is
summarized and condensed using a concise splice graph.
The splice graph is then decomposed into a collection of
ASMs, where more accurate abundance estimation and
differential testing will be performed. Our approach
directly localizes where differential splicing occurs,
making it easier to identify exons involved in alternative
transcription.
In comparison with differential analysis based on tran-
script quantification such as Cufflinks, DiffSplice isolates
(a) (b)
Figure 9. DiffSplice on the breast cancer data set. (a) Differential transcription on skipped exon in gene CD46 identified by DiffSplice. DiffSplice
discovered two ASMs in this gene. The second ASM that alternatively skipped the 13th exon was tested to have significantly higher skipping ratio in
MCF7 samples. This transcriptional difference has been validated by qRT-PCR experiment. (b) Differential transcription on retained intron in gene
NPC2 identified by DiffSplice. The exon-skipping event spanning the left three exons was tested to have significantly higher skipping ratio in MCF7
samples. The nested intron retention in the left two exons was also tested to have significantly higher ratio of retaining the intron in MCF7 samples.
The differential transcription in the intron-retention event has been validated by qRT-PCR experiment.
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the divergences in alternatively spliced regions from the
overall gene structure and alleviates potential false posi-
tives due to high complexity in transcription (e.g. large
number of transcripts), as shown in the lung differenti-
ation data set. Furthermore, DiffSplice is data driven.
It extracts information directly from RNA-seq read align-
ment and is capable of identifying alternative splicing
events involving novel transcripts such as novel exons
and novel splicing events. More than 100 novel ASMs
were discovered in the human lung cell transcriptome,
which might be potentially ignored by the methods using
annotated splicing features. In addition to alternative
splicing events, the identification of ASMs has been
further generalized to capture structural variations such
as insertions and deletions. The 42 differentially
transcribed insertion/deletion events discovered in the
breast cancer data set suggest possible cell line-specific
regulations by genomic aberrations.
To a biologist used to thinking about alternative
splicing as a collection of RNA isoforms, ASM highlights
the region(s) of a gene that vary among isoforms.
Ultimately, the biologist needs to know how differences
among isoforms result in a change in the biological
activity of the protein they encode. Investigation of the
functional and structural consequences of the alternate
exons may reveal what is occurring in genes with ASMs
(Supplementary Section S4). Do the exons in an ASM add
or remove a known motif? Does that motif require
changes in another part of the protein that is reflected in
the other ASM? Are the conserved regions the same
among samples? Do nested ASMs correspond to
hypervariable regions of the protein? In short, careful an-
notation of an ASM will typically reveal as much as an
inferred isoform with little to no risk of an inaccurate re-
construction. The detection and analysis of these local
events also can be significant in practice, as suggested by
the usage of existing methods. For example, MISO (15)
and MATS (17) work entirely on small (non-nested)
manually curated ASMs, and have been used by
researchers studying alternative splicing. Our method sub-
stantially generalizes the analysis and automatically
detects the alternative splicing events based on only read
alignments.
We use the average read coverage over an exonic region
instead of read count at each base as the observed expres-
sion. This approach smooths the sampling distribution
that might be perturbed during cDNA library preparation
by sampling bias, e.g. the sequence-specific bias (33,35).
The abundance estimation procedure further incorporates
the observed coverage around the alternatively spliced
regions on both exons and exon–exon junctions, to
improve the quantification accuracy of the transcription
flow. As demonstrated through the simulations, this
decomposition mechanism in DiffSplice naturally allevi-
ates the sampling bias associated with the position in tran-
scripts (30,33–35).
DiffSplice estimates the relative proportion of alterna-
tive transcription flows in every ASM and calculates the
JSD to quantify the difference in transcription between
samples. Although the relative proportion encodes the dis-
tribution of transcripts, it ignores information such as the
absolute expression level of every isoform in each sample,
which may carry statistical importance for assessment of,
e.g. the confidence of the estimated transcript expression.
Therefore, new tests for differential transcription may take
account of the expression level of transcripts after proper
normalization among samples.
DiffSplice is freely available to the academic research
community and can be downloaded at http://www.netlab.
uky.edu/p/bioinfo/DiffSplice. The software takes the
RNA-seq alignment files in standard SAM format as
input and generates ASMs in gtf format. When
uploaded to the UCSC genome browser, the ASMs with
significant differences across sample groups with a given
FDR are shown as highlighted tracks.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
Supplementary Figures 1–13, Supplementary Methods
and Supplementary References [36–38].
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